Endpoints News 生物医药· Max Bayer·· 18 天前AI 评分20
AbbVie 与 Brise Pharma 合作开发两款治疗偏头痛的在研药物
AbbVie, Brise disclose deal for two preclinical migraine meds
AI 导读
AbbVie 已与北京的 Brise Pharma 达成一项发现和商业化合作,涉及两款处于临床前阶段的偏头痛治疗药物。
正文
AbbVie has agreed to a discovery and commercialization deal with Brise Pharma for two preclinical migraine programs.
The Beijing-based partner
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news